+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biodefense - Market Analysis, Trends, and Forecasts

  • ID: 1056064
  • Report
  • 92 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Achaogen ,Inc.
  • Alnylam Pharmaceuticals
  • Altimmune
  • Anp Technologies , Inc.
  • Bavarian Nordic A/S
  • Cleveland Biolabs , Inc.
  • MORE
The Biodefense market worldwide is projected to grow by US$7 Billion, driven by a compounded growth of 6.5%. Vaccines, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.7%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$12.5 Billion by the year 2025, Vaccines will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 7.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$322.3 Million to the region's size and clout in the next 5 to 6 years. Over US$325.5 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Vaccines will reach a market size of US$960.7 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6.2% over the next couple of years and add approximately US$1.2 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Achaogen, Inc.
  • Alexeter Technologies, LLC
  • Alnylam Pharmaceuticals, Inc.
  • Altimmune, Inc.
  • ANP Technologies, Inc.
  • Bavarian Nordic A/S
  • Cleveland BioLabs, Inc.
  • Elusys Therapeutics, Inc.
  • Emergent BioSolutions, Inc.
  • Ichor Medical Systems, Inc.
  • New Horizons Diagnostic Corporation
  • PathSensors, Inc.
  • Research International, Inc.
  • SIGA Technologies
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Achaogen ,Inc.
  • Alnylam Pharmaceuticals
  • Altimmune
  • Anp Technologies , Inc.
  • Bavarian Nordic A/S
  • Cleveland Biolabs , Inc.
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Biodefense Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Biodefense Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Biodefense Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Biodefense Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Vaccines (Product) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Vaccines (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Vaccines (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Biothreat Detection Devices (Product) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Biothreat Detection Devices (Product) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Biothreat Detection Devices (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Biodefense Market Share (in %) by Company: 2019 & 2025

TABLE 10: United States Biodefense Market Estimates and Projections in US$ Million by Product: 2018 to 2025

TABLE 11: Biodefense Market in the United States by Product: A Historic Review in US$ Million for 2009-2017

TABLE 12: United States Biodefense Market Share Breakdown by Product: 2009 VS 2019 VS 2025

CANADA

TABLE 13: Canadian Biodefense Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025

TABLE 14: Canadian Biodefense Historic Market Review by Product in US$ Million: 2009-2017

TABLE 15: Biodefense Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

JAPAN

TABLE 16: Japanese Market for Biodefense: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025

TABLE 17: Biodefense Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017

TABLE 18: Japanese Biodefense Market Share Analysis by Product: 2009 VS 2019 VS 2025

CHINA

TABLE 19: Chinese Biodefense Market Growth Prospects in US$ Million by Product for the Period 2018-2025

TABLE 20: Biodefense Historic Market Analysis in China in US$ Million by Product: 2009-2017

TABLE 21: Chinese Biodefense Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Biodefense Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 22: European Biodefense Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 23: Biodefense Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 24: European Biodefense Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: European Biodefense Market Estimates and Forecasts in US$ Million by Product: 2018-2025

TABLE 26: Biodefense Market in Europe in US$ Million by Product: A Historic Review for the Period 2009-2017

TABLE 27: European Biodefense Market Share Breakdown by Product: 2009 VS 2019 VS 2025

FRANCE

TABLE 28: Biodefense Market in France by Product: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 29: French Biodefense Historic Market Scenario in US$ Million by Product: 2009-2017

TABLE 30: French Biodefense Market Share Analysis by Product: 2009 VS 2019 VS 2025

GERMANY

TABLE 31: Biodefense Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025

TABLE 32: German Biodefense Historic Market Analysis in US$ Million by Product: 2009-2017

TABLE 33: German Biodefense Market Share Breakdown by Product: 2009 VS 2019 VS 2025

ITALY

TABLE 34: Italian Biodefense Market Growth Prospects in US$ Million by Product for the Period 2018-2025

TABLE 35: Biodefense Historic Market Analysis in Italy in US$ Million by Product: 2009-2017

TABLE 36: Italian Biodefense Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 37: United Kingdom Market for Biodefense: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025

TABLE 38: Biodefense Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017

TABLE 39: United Kingdom Biodefense Market Share Analysis by Product: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 40: Rest of Europe Biodefense Market Estimates and Forecasts in US$ Million by Product: 2018-2025

TABLE 41: Biodefense Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2009-2017

TABLE 42: Rest of Europe Biodefense Market Share Breakdown by Product: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 43: Biodefense Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 44: Asia-Pacific Biodefense Historic Market Scenario in US$ Million by Product: 2009-2017

TABLE 45: Asia-Pacific Biodefense Market Share Analysis by Product: 2009 VS 2019 VS 2025

REST OF WORLD

TABLE 46: Rest of World Biodefense Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025

TABLE 47: Rest of World Biodefense Historic Market Review by Product in US$ Million: 2009-2017

TABLE 48: Biodefense Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025

IV. COMPETITION

ACHAOGEN ,INC.

ALNYLAM PHARMACEUTICALS

ALTIMMUNE

ANP TECHNOLOGIES , INC.

BAVARIAN NORDIC A/S

CLEVELAND BIOLABS , INC.

ELUSYS THERAPEUTICS, INC.

EMERGENT BIOSOLUTIONS

ICHOR MEDICAL SYSTEMS, INC.

NEW HORIZONS DIAGNOSTIC CORPORATION

PATHSENSORS, INC.

RESEARCH INTERNATIONAL , INC.

SIGA TECHNOLOGIES

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Achaogen ,Inc.
  • Alnylam Pharmaceuticals
  • Altimmune
  • Anp Technologies , Inc.
  • Bavarian Nordic A/S
  • Cleveland Biolabs , Inc.
  • Elusys Therapeutics, Inc.
  • Emergent Biosolutions
  • Ichor Medical Systems, Inc.
  • New Horizons Diagnostic Corporation
  • Pathsensors, Inc.
  • Research International , Inc.
  • Siga Technologies
Note: Product cover images may vary from those shown
Adroll
adroll